Skip to main content

Animations

MJFF Publications

1171 - 1180 of 8587 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2020
  • 2020
  • 2020
  • 2022
  • 2020
  • 2022
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Parkinson disease-associated cognitive impairment
    Journal Name: Nature Reviews Disease Primers
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41572-021-00280-3
    Citation Count: 392
  • Summary Details
    RESTRICTED
    Title: The gut microbiota–brain axis in behaviour and brain disorders
    Journal Name: Nature Reviews Microbiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41579-020-00460-0
    Best OA location URL:
    Citation Count: 842
  • Summary Details
    RESTRICTED
    Title: LRRK2 in Parkinson disease: challenges of clinical trials
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-019-0301-2
    Best OA location URL:
    Citation Count: 277
  • Summary Details
    RESTRICTED
    Title: Mechanisms, regulation and functions of the unfolded protein response
    Journal Name: Nature Reviews Molecular Cell Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41580-020-0250-z
    Citation Count: 1111
  • Summary Details
    RESTRICTED
    Title: Aspirin and ibuprofen could lower risk of LRRK2 Parkinson disease
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-020-0394-7
    Citation Count: 12
  • Summary Details
    RESTRICTED
    Title: Multiple system atrophy
    Journal Name: Nature Reviews Disease Primers
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41572-022-00382-6
    Best OA location URL:
    Citation Count: 57
  • Summary Details
    RESTRICTED
    Title: Moving towards genomic therapy for amyotrophic lateral sclerosis
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-020-0393-8
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Blood GFAP as an emerging biomarker in brain and spinal cord disorders
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-021-00616-3
    Citation Count: 207
  • Summary Details
    RESTRICTED
    Title: Functional brain networks in the evaluation of patients with neurodegenerative disorders
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-022-00753-3
    Best OA location URL:
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Genome-wide analysis furthers decoding of Alzheimer disease genetics
    Journal Name: Nature Reviews Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41582-022-00678-x
    Best OA location URL:
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.